Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole Ointment for Non-healing Pilonidal Sinus Wounds
NCT04273997Phase 2Unknown
- Sponsor
- SLA Pharma
- Start
- Oct 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in pilonidal sinus comparing Metronidazole Ointment with Placebo Ointment (2 arms). Primary endpoint: Proportion of subjects with complete healing at 6 weeks. Status: unknown.
02
Drugs
metronidazole
03
Conditions
pilonidal sinus
Beyond the preview
Go deeper on NCT04273997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04273997.